我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
Unknown
100.0%
暂无批准数据
- The global connected drug delivery devices market is projected to grow from $5.3 billion in 2026 to $12.7 billion by 2035, representing a compound annual growth rate of 10.2%. - Rising chronic disease prevalence including diabetes, asthma, and COPD is driving demand for connected devices that enable precise dosing and long-term therapy management. - Bluetooth-enabled smart wearable injectors currently dominate the market, with over 80 manufacturers offering various connected drug delivery solutions primarily for parenteral administration. - North America leads the market share while Asia-Pacific is expected to experience the highest growth rate through 2035, driven by biopharmaceutical startups and increased device approvals.
